The SF-36 and SGRQ: validity and first look at minimum important differences in IPF

類似資料

• The six-minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference
  著者:: Swigris, Jeffrey J., 等
  出版事項: (2009)
• Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trial
  著者:: Raghu, Ganesh, 等
  出版事項: (2009)
• What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
  著者:: Ogura, Koichi, 等
  出版事項: (2020)
• Development of the ATAQ-IPF: a tool to assess quality of life in IPF
  著者:: Swigris, Jeffrey J, 等
  出版事項: (2010)
• CORR Insights®: What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
  著者:: Janssen, Stein J.
  出版事項: (2020)